Quipt Home Medical Corp (TSX:QIPT)

C$ 3.56 0 (0%) Market Cap: 153.40 Mil Enterprise Value: 270.54 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 66/100

Q3 2024 Quipt Home Medical Corp Earnings Call Transcript
Aug 15, 2024

C$3.77 (-17.32%)

Earnings
Q2 2024 Quipt Home Medical Corp Earnings Call Transcript
May 16, 2024

C$4.62 (-14.44%)

Earnings
Q1 2024 Quipt Home Medical Corp Earnings Call Transcript
Feb 15, 2024

C$6.03 (-8.91%)

Earnings
Q4 2023 Quipt Home Medical Corp Earnings Call Transcript
Dec 19, 2023

C$6.2 (-0.16%)

Earnings
Q3 2023 Quipt Home Medical Corp Earnings Call Transcript
Aug 15, 2023

C$7.38 (+2.07%)

Earnings
Quipt Home Medical Corp at Three Part Advisors East Coast Ideas Conference (Virtual) Transcript
Jun 21, 2023
Q2 2023 Quipt Home Medical Corp Earnings Call Transcript
May 16, 2023

C$8.1 (-7.00%)

Earnings
Q1 2023 Quipt Home Medical Corp Earnings Call Transcript
Feb 14, 2023

C$8.45

Earnings
Q4 2022 Quipt Home Medical Corp Earnings Call Transcript
Dec 22, 2022

C$6.31 (-0.63%)

Earnings
Q3 2022 Quipt Home Medical Corp Earnings Call Transcript
Aug 16, 2022

C$6.97 (-1.69%)

Earnings
Q2 2022 Quipt Home Medical Corp Earnings Call Transcript
May 17, 2022

C$5.64 (+0.71%)

Earnings
Q4 2021 Quipt Home Medical Corp Earnings Call Transcript
Feb 01, 2022

C$6.83 (+1.79%)

Earnings
Q3 2021 Quipt Home Medical Corp Earnings Call Transcript
Aug 24, 2021

C$8.5 (+11.55%)

Earnings
Q2 2021 Quipt Home Medical Corp Earnings Call Transcript
Jun 01, 2021

C$7.89 (-5.73%)

Earnings
Q1 2021 Protech Home Medical Corp Earnings Call Transcript
Mar 02, 2021

C$8.48

Earnings
Q4 2020 Protech Home Medical Corp Earnings Call Transcript
Feb 02, 2021

C$8.24 (+0.49%)

Earnings
Q3 2020 Protech Home Medical Corp Earnings Call Transcript
Aug 18, 2020

C$4.64 (-0.85%)

Earnings
Q2 2020 Protech Home Medical Corp Earnings Call Transcript
May 20, 2020

C$4.28 (+1.90%)

Earnings
Q1 2020 Protech Home Medical Corp Earnings Call Transcript
Feb 26, 2020

C$3.28

Earnings
Q4 2019 Protech Home Medical Corp Earnings Call Transcript
Jan 29, 2020

C$3.72 (+3.33%)

Earnings
Q3 2019 Protech Home Medical Corp Earnings Call Transcript
Aug 20, 2019

C$3.2 (-1.23%)

Earnings
Q2 2019 Protech Home Medical Corp Earnings Call Transcript
May 22, 2019

C$3.28 (-5.75%)

Earnings
Q2 2019 Protech Home Medical Corp Earnings Call Transcript
Apr 02, 2019

C$3.96 (+2.06%)

Earnings

Quipt Home Medical Corp at Three Part Advisors East Coast Ideas Conference (Virtual) Transcript

Jun 21, 2023 / 10:00AM GMT

Release Date Price: C$7.54 (+6.95%)

Transcript

Dave Mossberg

Three Part Advisors - Moderator

Well, everyone. It's Dave Mossberg from Three Part Advisors, and I want to welcome everyone to our East Coast IDEAS Conference. Our next session will be with Quipt Home Medical Corp. Trades on the Nasdaq under the ticker symbol QIPT. It's a good business and it's the first time they've done one of events. I'm really happy to have them here. And from the company, we have the CEO and Chairman, Greg Crawford. And with that, I'll turn it over to Greg.

Greg Crawford

Quipt Home Medical Corp. - Chairman of the Board & CEO

Thank you. I appreciate that introduction, and thanks, everyone, for joining us today. I'm Greg Crawford. I'm the Chairman and Chief Executor of Quipt Home Medical. Quipt Home Medical provides primarily respiratory devices to patients in their home. Today, Quipt sits at about $230 million of run rate total revenue and $52 million worth of run rate adjusted EBITDA. We complete over 690,000-plus annual deliveries to over 270,000 patient lives through over 30,000 referring physicians. We're currently

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.